Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

Open access

Abstract

Anemia of inflammation develops in settings of chronic inflammatory, infectious, or neoplastic disease. In this highly prevalent form of anemia, inflammatory cytokines, including IL-6, stimulate hepatic expression of hepcidin, which negatively regulates iron bioavailability by inactivating ferroportin. Hepcidin is transcriptionally regulated by IL-6 and bone morphogenetic protein (BMP) signaling. We hypothesized that inhibiting BMP signaling can reduce hepcidin expression and ameliorate hypoferremia and anemia associated with inflammation. In human hepatoma cells, IL-6-induced hepcidin expression, an effect that was inhibited by treatment with a BMP type I receptor inhibitor, LDN-193189, or BMP ligand antagonists noggin and ALK3-Fc. In zebrafish, the induction of hepcidin expression by transgenic expression of IL-6 was also reduced by LDN-193189. In mice, treatment with IL-6 or turpentine increased hepcidin expression and reduced serum iron, effects that were inhibited by LDN-193189 or ALK3-Fc. Chronic turpentine treatment led to microcytic anemia, which was prevented by concurrent administration of LDN-193189 or attenuated when LDN-193189 was administered after anemia was established. Our studies support the concept that BMP and IL-6 act together to regulate iron homeostasis and suggest that inhibition of BMP signaling may be an effective strategy for the treatment of anemia of inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2010-10-313064

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 193

Metadata

Authors
Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., Szekely, B. A., Roy, C. N., Seehra, J. S., Cuny, G. D., Scadden, D. T., Peterson, R. T., Bloch, K. D., & Yu, P. B.
Affiliations
  • Harvard University (US)
  • Center for Regenerative Medicine at Massachusetts General Hospital and Harvard Medical School, Boston, MA;
  • Johns Hopkins University (US)
  • Acceleron Pharma (United States) (US)
  • Brigham and Women's Hospital (US)
Corresponding author
  • Steinbicker, Andrea U.
  • Sachidanandan, Chetana
  • Vonner, Ashley J.
  • Yusuf, Rushdia Z.
  • Bloch, Kenneth D.
  • Yu, Paul B.
Venue
Blood
Published
2011-05-05
Volume
117
Issue
18
Pages
4915-4923
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2058531588
Cited by
173
References
52
Citations by year
2026: 6 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 12 · 2020: 12 · 2019: 13 · 2018: 9 · 2017: 16 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 18 · 2012: 11
FWCI
12.25
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Heart, Lung, and Blood Institute (R01HL097794, K08HL079943)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082722, R01DK082971, K01DK065635)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR057374)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Keywords
anemia of chronic disease, BMP signaling, hepcidin, interleukin-6, iron homeostasis, hypoferremia, LDN-193189, ferroportin, microcytic anemia, chronic inflammation, turpentine-induced inflammation, zebrafish, hepatoma cells
MeSH terms
Noggin Protein, Anemia, Animals, Carrier Proteins, Hematopoietic Stem Cells, Humans, Inflammation, Mice, Inbred C57BL, Pyrazoles, Pyrimidines, Recombinant Proteins, Turpentine, Zebrafish, Signal Transduction, Interleukin-6, Bone Morphogenetic Proteins, Antimicrobial Cationic Peptides, Zebrafish Proteins, Mice, Bone Morphogenetic Protein Receptors, Type I, Hep G2 Cells, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. https://app.cochat.ai/papers/10.1182/blood-2010-10-313064
The paper
Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., Szekely, B. A., Roy, C. N., Seehra, J. S., Cuny, G. D., Scadden, D. T., Peterson, R. T., Bloch, K. D., & Yu, P. B. (2011). Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood. https://doi.org/10.1182/blood-2010-10-313064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.